PTU™ 50 mg Tablets (propylthiouracil)

There is currently a shortage of propylthiouracil in the Canadian market. Given the medical necessity of this product for patients in Canada, Health Canada has added Phebra’s PTU™ (propylthiouracil) 50 mg tablets to the List of Drugs for Exceptional Importation and Sale, as an interim measure to help mitigate the shortage.

Each PTU™ tablet contains 50 mg of propylthiouracil as the active ingredient. Excipient with known effect: lactose monohydrate. The tablet is gluten free.

PTU™ 50 mg Tablets are white, round, biconvex and uncoated. One side is debossed ‘PRESTAB’ and other side is plain.

Propylthiouracil is an antithyroid drug indicated for the total treatment of hyperthyroidism or in the treatment of the thyrotoxic patient prior to surgery or radioactive iodine therapy.

  • Strength: 50 mg tablets
  • Package: 100 tablet amber glass bottle
  • Status: Drugs for Exceptional Importation and Sale
  • Phebra Code: TAB001
  • Pack Size: 12 bottles